Naba Al Saha Medical Services Company (SASE: 9546)
Health Care · Health Care Providers & Services · SA
SR22.00
+2.18% today · -26.5% 1Y
Naba Al Saha Medical Services Company (SASE: 9546) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $123.05M.
Over the last twelve months the share price has lost 26.5%, trading between 20.00 and 30.95.
Tweenvest scores Naba Al Saha Medical Services Company across four factors: quality 78/100, value 64/100, growth 51/100. Its strongest factor is quality.
9546 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $123.05M
- Revenue (TTM)
- $54.87M
- P/E
- 16.18
- EPS
- 1.36
- Dividend yield
- —
- Beta (5Y)
- -0.34
- 52-week high
- SR30.95
- 52-week low
- SR20.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.00M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Novolog (Pharm-Up 1966) LtdTASE: NVLG | $129.58M | ₪0.78 | -17.08% |
| Alf Meem Yaa for Medical Supplies and Equipment CompanySASE: 9527 | $129.48M | SR69.45 | +15.75% |
| Global Cord Blood CorporationOTCPK: CORB.F | $127.35M | $0.95 | -0.01% |
| Ekachai Medical Care Public Company LimitedSET: EKH | $123.98M | ฿5.20 | +0.97% |
| Sopharma Trading ADBUL: SFT | $122.81M | €3.20 | +1.91% |
| TSUMUGU Holdings, Inc.SPSE: 3055 | $121.14M | ¥932.00 | -0.53% |
| Kindstar Globalgene Technology, Inc.SEHK: 9960 | $119.18M | HK$0.94 | +4.44% |
| Remus Pharmaceuticals LimitedNSEI: REMUS | $118.88M | Rs976.35 | +13.29% |
Figures last refreshed Oct 11, 2026.